News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Koppel Adam
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Disposed of 432,627 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 06/08/2023 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Koppel Adam (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 16,000 options to buy
@ $13.81, valued at
$221k
|
|
| 06/16/2022 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 23,459 options to buy
@ $24.35, valued at
$571.2k
|
|
| 05/31/2022 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.5, valued at
$20k
|
|
| 12/29/2021 |
4
| Koppel Adam (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Unknown transaction of 3,080,237 shares
@ $38.25, valued at
$117.8M
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
Disposed/sold 25,000 options to buy
@ $3.47, valued at
$86.8k
Disposed/sold 25,000 options to buy
@ $13.08, valued at
$327k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 08/12/2021 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 1,000,000 shares
@ $70.25, valued at
$70.3M
|
|
| 07/21/2021 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.|
Txns:
| Converted 6,999,998 shares
@ $0
Converted 1,334,562 shares
@ $0
Bought 100,000 shares
@ $20, valued at
$2M
Converted 35,000,001 options to buy
@ $0
Converted 6,672,819 options to buy
@ $0 |
|
| 07/14/2021 |
4
| Koppel Adam (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 12,530 options to buy
@ $9.4, valued at
$117.8k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.59, valued at
$103.6k
|
|
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 1,450,000 shares
@ $71.5, valued at
$103.7M
|
|
| 01/05/2021 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 5,508 options to buy
@ $3.46, valued at
$19.1k
|
|
| 12/14/2020 |
4
| Koppel Adam (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 1,000,000 shares
@ $23.4, valued at
$23.4M
|
|
| 12/11/2020 |
4
| Koppel Adam (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 3,189,189 shares
@ $3.7, valued at
$11.8M
|
|
| 11/12/2020 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Bought 332,293 shares
@ $10.3, valued at
$3.4M
|
|
| 10/29/2020 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Acquired 49,961,943 shares
@ $0
Bought 10,000,000 shares
@ $10, valued at
$100M
|
|
| 10/27/2020 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 3,333,333 shares
@ $3, valued at
$10M
|
|
| 10/26/2020 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on BCLS Acquisition Corp.|
Txns:
| Granted 487,500 shares
@ $10, valued at
$4.9M
|
|
| 10/02/2020 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 5,663 options to buy
@ $3.38, valued at
$19.1k
|
|
| 07/28/2020 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Annexon, Inc.|
Txns:
| Converted 2,522,385 shares
@ $0
Converted 319,243 shares
@ $0
Bought 400,000 shares
@ $17, valued at
$6.8M
Converted 22,222,221 preferred shares
@ $0
Converted 2,812,543 preferred shares
@ $0 |
|
| 07/02/2020 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 4,370 options to buy
@ $4.17, valued at
$18.2k
|
|
| 06/18/2020 |
4
| Koppel Adam (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.03, valued at
$90.9k
Granted 10,000 options to buy
@ $3.03, valued at
$30.3k
|
|
| 06/16/2020 |
4
| Koppel Adam (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 3,333 restricted stock units
@ $0
Granted 15,000 options to buy
@ $21.61, valued at
$324.2k
|
|
| 05/22/2020 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.84, valued at
$153.6k
|
|
| 04/02/2020 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 8,296 options to buy
@ $2.16, valued at
$17.9k
|
|
| 02/06/2020 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Converted 2,825,602 shares
@ $0
Converted 859,573 shares
@ $0
Bought 294,117 shares
@ $17, valued at
$5M
Converted 2,825,602 preferred shares
@ $0
Converted 859,573 preferred shares
@ $0 |
|
| 01/16/2020 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 3,333,333 shares
@ $3, valued at
$10M
|
|
| 12/06/2019 |
4
| Koppel Adam (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 1,500,000 shares
@ $24.68, valued at
$37M
|
|
|
|
|